Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
66.00
-1.05 (-1.57%)
Nov 11, 2026, 12:06 PM EST - Market open
Celcuity Market Cap
Celcuity has a market cap or net worth of $3.24 billion as of November 11, 2026. It is the 4,823rd most valuable company in the world and the 1,446th biggest in the United States. Its market cap has decreased by 0.36% in one year.
Market Cap
3.24B
Enterprise Value
3.35B
1-Year Change
-0.36%
Global Rank
Country Rank
#1,446 United States
Category
ChartMarket Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $3.24B, an increase of 2,321.46%. That is a compound annual growth rate of 41.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 3.24B | -29.75% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tango Therapeutics | 3.63B |
| Disc Medicine | 3.59B |
| Parabilis Medicines | 3.52B |
| Viking Therapeutics | 3.42B |
| Dyne Therapeutics | 3.39B |
| Tarsus Pharmaceuticals | 3.38B |
| Viridian Therapeutics | 3.24B |
| Arcutis Biotherapeutics | 3.23B |